There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Veru Inc (NASDAQ:VERU) and Kratos Defense (NASDAQ:KTOS) with bullish sentiments.
Veru Inc (VERU)
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to Veru Inc, with a price target of $10. The company’s shares opened today at $2.08.
McCarthy said:
“Xtandi (enzaluatamide) was approved for non-metastatic castration resistant prostate cancer (nmCRPC)…significant news for the PC space, in our view, and a positive for Veru.”
According to TipRanks.com, McCarthy is a 4-star analyst with an average return of 10.7% and a 43.1% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as IntelliPharmaCeutics International, SELLAS Life Sciences Group Inc, and ContraVir Pharmaceuticals Inc.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Veru Inc with a $7.50 average price target.
See today’s analyst top recommended stocks >>
Kratos Defense (KTOS)
In a report released today, Kenneth Herbert from Canaccord Genuity maintained a Buy rating on Kratos Defense, with a price target of $15. The company’s shares opened today at $12.83.
According to TipRanks.com, Herbert is a 5-star analyst with an average return of 12.8% and a 65.6% success rate. Herbert covers the Consumer Goods sector, focusing on stocks such as Transdigm Group Inc, CPI Aerostructures, and Spirit AeroSystems.
Kratos Defense has an analyst consensus of Strong Buy, with a price target consensus of $15.33, implying a 19.5% upside from current levels. In a report released today, B.Riley FBR also assigned a Buy rating to the stock with a $16 price target.
.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
